Vimarsana
Biggest News Aggregation in the World

Page 2 - Supplemental Appendix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Supplemental Appendix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Supplemental Appendix Today - Breaking & Trending Today

Yes, Virginia, unlike CAM, science-based medicine does change based on science - Vimarsana News

Yes, Virginia, unlike CAM, science-based medicine does change based on science

By oracknows on August 2, 2013. "Alternative medicine," so-called "complementary and alternative medicine" (CAM), or, as it's become fashionable to call it, "integrative medicine" is a set of medical practices that are far more based on belief than science. As my good bud and collaborator Mark Crislip so pointedly reminded us last week, CAM is far more akin to religion than science-based medicine (SBM). However, as I've discussed more times than I can remember over the years, both here and at my not-so-super-secret-other blog, CAM practitioners and advocates, despite practici...

A Document Maven Looks at the Pfizer Vaccine Paper in the New England Journal of Medicine - Vimarsana News

A Document Maven Looks at the Pfizer Vaccine Paper in the New England Journal of Medicine

By Lambert Strether of Corrente As it turns out, I have narrow but deep expertise relevant to the discussion of the New England Journal of Medicine (NEJM) paper on the Pfizer vaccine study, “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine” (“Safety and Efficacy”), so I thought I’d weigh in, albeit a little late, on the protocols and “exclusion criteria” discussion. In a past life, several careers ago, I consulted to various large firms, among them medical publishers, on complex document structures; my deliverable would be a formal definition of such structures, plus do...

Further Discussion of the Red Flags in the Pfizer Vaccine Paper in the New England Journal of Medicine - Vimarsana News

Further Discussion of the Red Flags in the Pfizer Vaccine Paper in the New England Journal of Medicine

The European FDA equivalent is poised to issue an statement of approval for the Pfizer candidate next Monday and the Comission states that it will subject the approval to conditional but ultrafast commercialization procedures under pressure from German authorities now seeing, not overwhelming but high hospitalization and casualty numbers. Rather than in the NEJM publication I wish that all statements by the Agency and issues are treated with the required transparency. We will see. apleb You cannot really have transparency if you need to be a fully accredited MD with virology or similar specia...